Safety

GI Side Effects Management

Comprehensive guide to managing gastrointestinal adverse effects of GLP-1 receptor agonists

Common GI Side Effects

Nausea 44-70%

Timing: Early (first 4 weeks)

Severity: Usually mild-moderate

  • Start low, go slow (lowest dose for 4 weeks)
  • Take with food if tolerated
  • Small, frequent meals
  • Ginger supplements (250mg 3x daily)
  • Consider prophylactic antiemetics
Vomiting 10-20%

Timing: Early (first 4-8 weeks)

Severity: Usually indicates need for dose reduction

  • Hold dose until symptoms resolve
  • Resume at lower dose
  • Ensure adequate hydration
  • If persistent >3 days, evaluate
  • Avoid taking dose if actively nauseated
Diarrhea 15-30%

Timing: Variable (any time)

Severity: Usually self-limiting

  • Usually transient
  • Stay hydrated
  • BRAT diet during episodes
  • Consider loperamide if persistent
  • Evaluate for other causes if chronic
Constipation 15-25%

Timing: Ongoing

Severity: Manageable

  • Increase fiber intake
  • Adequate hydration (2-3L water daily)
  • Regular physical activity
  • Stool softeners (docusate)
  • Osmotic laxatives if needed
Abdominal Pain 10-15%

Timing: Variable

Severity: Usually mild

  • Usually transient
  • May be related to slowed gastric emptying
  • Evaluate for pancreatitis if severe
  • Consider dose reduction
  • PPIs may help some patients
GERD/Heartburn 10-20%

Timing: Ongoing

Severity: Manageable

  • Elevate head of bed
  • Avoid lying down after meals
  • Small meals, eat slowly
  • Avoid trigger foods
  • Consider PPI therapy

Risk Factors for GI Intolerance

Female sex

2-3x higher risk

Younger age

Higher nausea risk

Rapid dose escalation

Significantly increased

Higher dose

Dose-dependent increase

No prior GLP-1 use

Naive patients at higher risk

Low baseline BMI

More GI symptoms

Prevention Strategies

Start Low, Go Slow

Initiate at lowest dose (e.g., semaglutide 0.25mg) and stay for 4+ weeks before escalating. This allows tolerance to develop.

Take With Food

Taking the injection with a meal or shortly after can reduce nausea for many patients. Some do better on empty stomach - individualize.

Hydration & Small Meals

Small, frequent meals (4-6/day) rather than large meals. Sip fluids throughout the day. Avoid lying down after eating.

Timing of Dose

Some patients tolerate evening injections better (sleep through initial nausea). Others prefer morning (can manage if nauseated during day).

Prophylactic Antiemetics

Consider short-term ondansetron 4-8mg PRN during titration. May reduce nausea enough to improve adherence.

Dosing Strategies for GI Tolerance

Strategy Description
Standard Titration4 weeks at each dose level - recommended for most patients
Extended Titration8-12 weeks at each dose for patients with significant GI symptoms
Split DosingSome patients tolerate 0.25mg twice weekly vs 0.5mg weekly
Back-loaded DosingTake larger portion of weekly dose later in week if symptoms occur after injection

Red Flag Symptoms

Discontinue GLP-1 therapy and seek medical evaluation if any of these occur:

Severe persistent abdominal pain
Vomiting that prevents keeping fluids down for 12+ hours
Signs of dehydration (dizziness, dark urine, dry mouth)
Inability to pass gas or stool (possible ileus)
Pancreatitis symptoms (severe pain, elevated lipase)
GI bleeding

Long-term Tolerance

Good News

  • Most GI symptoms improve over time (2-3 months)
  • Nausea typically decreases with continued treatment
  • Patients who persist usually have good long-term tolerance
  • Benefits (weight loss, glycemic control) often outweigh initial GI discomfort

Patient Counseling Points

  • Explain that GI symptoms are common but usually temporary
  • Set expectations: 2-4 weeks for initial tolerance
  • Provide clear instructions for managing symptoms
  • Give permission to hold dose if needed (don't suffer)
  • Follow up within first month to assess tolerance